LOS ALTOS, CA – Bioz, Inc., the world’s most comprehensive A.I. search engine for scientific experimentation, is proud to announce a new partnership with DNASTAR, a software company that has been meeting the needs of life scientists for nearly 35 years. DNASTAR software supports molecular biology, structural biology and genomics. Bioz is a life science literature-exploration […]

Shimadzu Scientific Instruments (SSI), the leading provider of cannabis testing instruments, and EVIO Labs Florida announce a collaborative relationship to support state-of-the-art testing services for licensed cannabis producers and distributors that must ensure their products are safe for patients and compliant with state regulations. EVIO Labs Florida, an independent third-party medical marijuana testing laboratory and […]

LOS ALTOS, CA – Bioz, Inc., the world’s most comprehensive A.I. search engine for scientific experimentation, is proud to announce a new partnership with DNASTAR, a software company that has been meeting the needs of life scientists for nearly 35 years. DNASTAR software supports molecular biology, structural biology and genomics. Bioz is a life science literature-exploration […]

Precision BioSciences gains rights to MaxCyte’s cell engineering technology to develop next-generation, oncology-focused, cell therapies with Precision’s ARCUS® genome-editing technology DURHAM, NC, and GAITHERSBURG, MD – Precision BioSciences (Precision) and MaxCyte today announced they have entered into a non-exclusive, clinical and commercial license agreement that will allow Precision to use MaxCyte’s Flow Electroporation® technologies to robustly […]

BioLegend, a world-class antibody provider, announced today a new partnership with VIB, a leading life science research institute in Flanders (Belgium), to evaluate and implement the TotalSeqTM antibodies for next-generation multi-omics by the combining single cell transcriptomics with single cell proteomics profiling. Early this year, an exclusive license agreement was announced between BioLegend and the […]

inDrop™ System selected to generate predictive multi-omic clinical research data for undiagnosed conditions with immune dysfunction CAMBRIDGE, Mass., and MOUNTAIN VIEW, Calif. – 1CellBio Inc., a leading single-cell analysis company serving the biomedical research community, today announced a partnership agreement with the Open Medicine Institute (OMI), a leading independent precision medicine clinical and research organization. […]

HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company has been awarded a contract for iQ-Check real-time PCR pathogen detection test kits and the iQ-Check Prep Automation System from the United States Department of Agriculture’s Food Safety and Inspection Service […]

First end-to-end workflow for multi-species screening and identification BASINGSTOKE, England — Thermo Fisher Scientific announced the introduction of a new, complete next generation sequencing (NGS) workflow for multi-species screening and identification for food authenticity. This comes after Oxoid Ltd. (a part of Thermo Fisher Scientific) and SGS MOLECULAR, S.A. signed a global co-marketing and distribution agreement that […]

–CRISPR Therapeutics Gains Additional Rights to MaxCyte’s Cell Engineering Technology to Develop CRISPR/Cas9-Based Cell Therapies in Immuno-Oncology– ZUG, SWITZERLAND, CAMBRIDGE, MASS. and GAITHERSBURG, MD – CRISPR Therapeutics (NASDAQ:CRSP) and MaxCyte today announced the expansion of their existing relationship by entering into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation® […]

VaxArray to improve potency testing for MR vaccines with support from Bill & Melinda Gates Foundation BOULDER — InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles (M) and rubella vaccines sponsored by the Bill & Melinda Gates Foundation. The long-term objective is to create in […]